ON
Oncology Pharma Inc.
ONPH · OTC
$0.06 -0.15% (-$0.00)
1M +18.00%
Market Cap $2.76M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
-
N/A ROIC N/A
ROE N/A
ROA N/A
Debt
-
N/A Debt/Equity N/A
Current ratio N/A
Int. coverage N/A
Stability
19 /100
Unstable Beta -0.13x
EPS volatility 3,237.90%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ONPH
Online
Sector
Healthcare
Industry
Biotechnology
CEO
George Malesek
Employees
1
Headquarters
San Francisco